<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; PerkinElmer Inc</title>
	<atom:link href="http://www.stockbloghub.com/tag/perkinelmer-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(ACHN) Company News for September 9, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/09/09/achn-company-news-for-september-9-2011-corporate-summary/82883</link>
		<comments>http://www.stockbloghub.com/2011/09/09/achn-company-news-for-september-9-2011-corporate-summary/82883#comments</comments>
		<pubDate>Fri, 09 Sep 2011 17:31:05 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Achillion Pharmaceuticals Inc]]></category>
		<category><![CDATA[ACHN]]></category>
		<category><![CDATA[Caliper Life Sciences Inc]]></category>
		<category><![CDATA[CALP]]></category>
		<category><![CDATA[Casey's General Stores Inc.]]></category>
		<category><![CDATA[CASY]]></category>
		<category><![CDATA[G-III Apparel Group Limited]]></category>
		<category><![CDATA[GIII]]></category>
		<category><![CDATA[GKK]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[Gramercy Capital Corporation]]></category>
		<category><![CDATA[PerkinElmer Inc]]></category>
		<category><![CDATA[Piper Jaffray Companies]]></category>
		<category><![CDATA[PJC]]></category>
		<category><![CDATA[PKI]]></category>
		<category><![CDATA[SFD]]></category>
		<category><![CDATA[SILC]]></category>
		<category><![CDATA[Silicom Limited]]></category>
		<category><![CDATA[Smithfield Foods Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82883</guid>
		<description><![CDATA[•    Smithfield Foods (NYSE:SFD) posted Q1 EPS of $0.69, surpassing the Zacks Consensus Estimate of $0.68 per share. Revenues for the quarter rose 6.6% year-over-year to $3.09 billion •    PerkinElmer, Inc. (NYSE:PKI) said it will acquire Caliper Life Sciences Inc. (NASDAQ:CALP) in a deal worth about $600 million. Following this development, shares of the genomic-detection tech maker advanced 41.14% to close at $10.43 •    Shares of retailer Casey’s General Stores, Inc. (NASDAQ:CASY) declined 6.54% after the company reported first-quarter earnings results that came in below the Street’s expectations •    Zagat, which provides reviews of bars, restaurants and shopping locations, will be acquired by Google (NASDAQ:GOOG). However, Google remained silent on the terms and conditions of the deal •    Clothing and luggage maker G-III Apparel Group, Ltd.’s (NASDAQ:GIII) share prices fell ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/09/achn-company-news-for-september-9-2011-corporate-summary/82883/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PKI) PerkinElmer Incorporated &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2011/06/30/pki-perkinelmer-incorporated-bull-of-the-day/77994</link>
		<comments>http://www.stockbloghub.com/2011/06/30/pki-perkinelmer-incorporated-bull-of-the-day/77994#comments</comments>
		<pubDate>Thu, 30 Jun 2011 21:17:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[PerkinElmer Inc]]></category>
		<category><![CDATA[PKI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77994</guid>
		<description><![CDATA[We upgrade our rating for PerkinElmer, Inc. (PKI) to Outperform based on solid results and benefits from reorganization. First-quarter 2011 earnings per share of $0.34 surpassed the Zacks Consensus Estimate of $0.30. PerkinElmer is a leader in several life science segments. It has added new related areas as part of its reorganization and divested unrelated businesses. As a consequence, it has emerged as a higher-growth, higher-margin company. Its operations, both sales and manufacturing, are diversified on a geographic basis. The company has implemented cost containment measures. Growing recurring revenue stream and operating margin expansion are its pillars of strength. Based on the company&#8217;s recent performance, we upgrade our rating on the stock to Outperform with a price target of $31, which is based on a P/E of approximately 18.6X our ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/30/pki-perkinelmer-incorporated-bull-of-the-day/77994/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PKI) PerkinElmer Analyst Upgrades Shares to Outperform</title>
		<link>http://www.stockbloghub.com/2011/06/29/pki-perkinelmer-analyst-upgrades-shares-to-outperform/77763</link>
		<comments>http://www.stockbloghub.com/2011/06/29/pki-perkinelmer-analyst-upgrades-shares-to-outperform/77763#comments</comments>
		<pubDate>Wed, 29 Jun 2011 16:41:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[PerkinElmer Inc]]></category>
		<category><![CDATA[PKI]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77763</guid>
		<description><![CDATA[We upgrade our rating on PerkinElmer (PKI) to Outperform based on solid results and benefits accruing from extensive reorganization. First-quarter 2011 earnings per share of 34 cents surpassed the Zacks Consensus Estimate of 30 cents. Revenues from continuing operations came in at $447.9 million, also sailing past the Zacks Consensus Estimate. PerkinElmer is a leader in several life science segments and it has added new related areas as part of its reorganization while divesting unrelated businesses. As a consequence, it has emerged as a higher-growth, higher-margined company focused on human and environmental health. PerkinElmer competes with Thermo Fisher Scientific (TMO) among others. The company views proteomics and genetic screening technologies as its thrust areas in the life sciences segment and it has made investments in high-content screening, proteomics, systems biology ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/29/pki-perkinelmer-analyst-upgrades-shares-to-outperform/77763/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PKI) PerkinElmer Presents Corporate Social Responsibility Report</title>
		<link>http://www.stockbloghub.com/2011/06/22/pki-perkinelmer-presents-corporate-social-responsibility-report/77141</link>
		<comments>http://www.stockbloghub.com/2011/06/22/pki-perkinelmer-presents-corporate-social-responsibility-report/77141#comments</comments>
		<pubDate>Wed, 22 Jun 2011 21:11:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[PerkinElmer Inc]]></category>
		<category><![CDATA[PKI]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77141</guid>
		<description><![CDATA[A global leader in human and environmental health, PerkinElmer (PKI) recently released its Corporate Social Responsibility (“CSR”) Report for 2010. This report provides information on the company’s achievements against its worldwide sustainability target, established in 2009, for environmental health and safety, community activities and product leadership. According to PerkinElmer, it has made solid progress, on account of its over 6,000 employees, to become a more socially responsible entity. In April 2011, the company launched its “For the Better Day” program with the purpose of donating time to voluntary service. PerkinElmer’s CSR objectives concentrate on seamlessly intertwining social and environmental requisites into every aspect of business operation. To achieve these goals, PerkinElmer has recognized three strategic bulwarks each with their own set of targets. With regard to the first pillar, Environment, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/22/pki-perkinelmer-presents-corporate-social-responsibility-report/77141/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VRSN) VeriSign Sells Business Unit to Symantec Corporation</title>
		<link>http://www.stockbloghub.com/2010/05/23/vrsn-verisign-sells-business-unit-to-symantec-corporation/38003</link>
		<comments>http://www.stockbloghub.com/2010/05/23/vrsn-verisign-sells-business-unit-to-symantec-corporation/38003#comments</comments>
		<pubDate>Sun, 23 May 2010 20:28:36 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Internet Software & Services]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[PerkinElmer Inc]]></category>
		<category><![CDATA[PKI]]></category>
		<category><![CDATA[Sasol Limited]]></category>
		<category><![CDATA[SSL]]></category>
		<category><![CDATA[Symantec Corporation]]></category>
		<category><![CDATA[SYMC]]></category>
		<category><![CDATA[VeriSign Inc.]]></category>
		<category><![CDATA[VRSN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=38003</guid>
		<description><![CDATA[VeriSign Inc. (VRSN) recently announced that it would sell its Authentication Services business to Symantec Corp. (SYMC) for approximately $1.28 billion in cash. The Authentication Services business includes Secure Sockets Layer (SSL) encryption certification services, the managed Public Key Infrastructure (PKI) platform and the company&#8217;s ownership stake in VeriSign Japan. Collectively, this business contributed approximately $101.9 million or 39% to the top-line in the March quarter. Symantec will acquire the assets of VeriSign&#8217;s Authentication Services business Incorporatedluding its ownership stake in VeriSign Japan as well as certain brands and trademarks. The transaction is expected to close in 60 to 90 days or upon receipt of regulatory approval. Following the close of this transaction, VeriSign&#8217;s remaining business will consist of its Naming Services business. This contributed approximately $162 million or 61% to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/23/vrsn-verisign-sells-business-unit-to-symantec-corporation/38003/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PKI) PerkinElmer Signs to Aquire Signature Genomic Laboratories</title>
		<link>http://www.stockbloghub.com/2010/04/20/pki-perkinelmer-signs-to-aquire-signature-genomic-laboratories/34388</link>
		<comments>http://www.stockbloghub.com/2010/04/20/pki-perkinelmer-signs-to-aquire-signature-genomic-laboratories/34388#comments</comments>
		<pubDate>Tue, 20 Apr 2010 20:50:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[PerkinElmer Inc]]></category>
		<category><![CDATA[PKI]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=34388</guid>
		<description><![CDATA[PerkinElmer Inc. (PKI) announced recently that it has agreed to acquire Signature Genomic Laboratories LLC, a diagnostic genetic testing company. The transaction is expected to close in May 2010. As per the filing with the US Securities and Exchange Commission (SEC), PerkinElmer will acquire the company for $90 million in cash. The deal should enable PerkinElmer strengthen its genetic testing service business and expand its position in early detection of the disease, specifically in the molecular diagnostics market. Furthermore, the deal will bolster PerkinElmer’s position in cancer diagnostics. Through this acquisition, PerkinElmer gains access to strong complementary assets that help in diagnosing disorders that often remain undetected by traditional genetic tests. Furthermore, the broader portfolio will benefit patients, researchers and doctors alike as accurate diagnosis is necessary to treat and ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/20/pki-perkinelmer-signs-to-aquire-signature-genomic-laboratories/34388/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PKI) PerkinElmer&#8217;s Earnings Report Beats Consensus Estimates</title>
		<link>http://www.stockbloghub.com/2010/02/05/pki-perkinelmers-earnings-report-beats-consensus-estimates/27201</link>
		<comments>http://www.stockbloghub.com/2010/02/05/pki-perkinelmers-earnings-report-beats-consensus-estimates/27201#comments</comments>
		<pubDate>Sat, 06 Feb 2010 01:17:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[PerkinElmer Inc]]></category>
		<category><![CDATA[PKI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=27201</guid>
		<description><![CDATA[PerkinElmer Inc. (PKI) reported fourth quarter (ended Jan 3, 2010) earnings (excluding special items) of 43 cents per share, which was above the Zacks Consensus Estimate by 2 cents. The company had earned 46 cents in the year-ago quarter. For full year 2009, the company earned (excluding special items) $1.27 per share, which was above the Zacks Consensus Estimate by 2 cents. The company had earned $1.41 in fiscal 2008. Estimate Revisions Trend There were no estimate revisions in either direction over the last 30 days from the 6 analysts covering the stock for the next quarter. The lack of directional pressure for the next quarter justifies our short-term recommendation reflected by Zacks Rank #3 (Hold). Furthermore, over the last 30 days, none of the analysts covering the stock revised ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/05/pki-perkinelmers-earnings-report-beats-consensus-estimates/27201/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PKI) PerkinElmer Tops Earnings Estimates</title>
		<link>http://www.stockbloghub.com/2009/11/01/pki-perkinelmer-tops-earnings-estimates/19297</link>
		<comments>http://www.stockbloghub.com/2009/11/01/pki-perkinelmer-tops-earnings-estimates/19297#comments</comments>
		<pubDate>Sun, 01 Nov 2009 22:21:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[PerkinElmer Inc]]></category>
		<category><![CDATA[PKI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19297</guid>
		<description><![CDATA[PerkinElmer Inc. (PKI) reported third-quarter earnings of 30 cents per share, which was 3 cents ahead of the Zacks Consensus Estimate. The company had earned 34 cents in the year-ago quarter. Revenues for the quarter came in at $437.1 million as against $478.7 million in the previous year period, a decline of 8.7%. On a segment basis, sales in the Human Health division declined approximately 8% to $180.2 million from $196.7 million in the year-ago quarter. Sales in the Environmental Health segment decreased approximately 9% to $256.9 million from $282.1 million in the year-ago quarter. The unfavorable impact of foreign exchange was 2%. However, acquisitions impacted revenues favorably by 1%. Revenues from the Human Health business accounted for 41% of the company’s total revenues in the quarter. Within Human Health, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/01/pki-perkinelmer-tops-earnings-estimates/19297/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

